Exact Mass: 460.1136

Exact Mass Matches: 460.1136

Found 48 metabolites which its exact mass value is equals to given mass value 460.1136, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Anhydroaureomycin

Anhydro-7-chlorotetracycline

C22H21ClN2O7 (460.1037)


   
   

Ponesimod

5-{[3-chloro-4-(2,3-dihydroxypropoxy)phenyl]methylidene}-3-(2-methylphenyl)-2-(propylimino)-1,3-thiazolidin-4-one

C23H25ClN2O4S (460.1223)


   

ParishinE

2-hydroxy-2-[2-oxo-2-[[4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]methoxy]ethyl]butanedioic acid

C19H24O13 (460.1217)


Parishin E is a natural product found in Gastrodia elata with data available. Parishin E, a parishin derivative isolated from Gastrodia elata, may have antioxidant property[1]. Parishin E, a parishin derivative isolated from Gastrodia elata, may have antioxidant property[1].

   

Parishin

2-hydroxy-2-[2-oxo-2-[[4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]methoxy]ethyl]butanedioic acid

C19H24O13 (460.1217)


Parishin E is a natural product found in Gastrodia elata with data available. Parishin E, a parishin derivative isolated from Gastrodia elata, may have antioxidant property[1]. Parishin E, a parishin derivative isolated from Gastrodia elata, may have antioxidant property[1].

   

7-O-6-O-Malonylcachinesidic acid

7-O-6-O-Malonylcachinesidic acid

C19H24O13 (460.1217)


   

(R)-4,4-dihydroxy-3-(4-dihydroxyphenyl)spiro{2,10-dioxatricyclo[12.2.2.13,7]nonadeca-1,(16),3,5,7(19),14,17-hexaene-12,2(5H)-furan}-11,5-dione|(R)-4,4-dihydroxy-3-(4-hydroxyphenyl)spiro{2,10-dioxatricyclo[12.2.2.13,7]nonadeca-1(17),3,5,7(19),14(18),15-hexaene-12,2(5H)-furan}-11,5-dione|retipolide E

(R)-4,4-dihydroxy-3-(4-dihydroxyphenyl)spiro{2,10-dioxatricyclo[12.2.2.13,7]nonadeca-1,(16),3,5,7(19),14,17-hexaene-12,2(5H)-furan}-11,5-dione|(R)-4,4-dihydroxy-3-(4-hydroxyphenyl)spiro{2,10-dioxatricyclo[12.2.2.13,7]nonadeca-1(17),3,5,7(19),14(18),15-hexaene-12,2(5H)-furan}-11,5-dione|retipolide E

C26H20O8 (460.1158)


   
   

dianellinone

dianellinone

C26H20O8 (460.1158)


   
   

parvifloral E

parvifloral E

C26H20O8 (460.1158)


   
   

2-[4-O-(beta-D-glucopyranosyl)benzyl] citrate

2-[4-O-(beta-D-glucopyranosyl)benzyl] citrate

C19H24O13 (460.1217)


   

3,3-Dimethyl-6-hydroxy-9beta-(1-methylethenyl)-11-methoxy-9a,13a-epoxy-3H,7H-4,14-dioxadibenz[a,j]anthracene-7,10,13-trione

3,3-Dimethyl-6-hydroxy-9beta-(1-methylethenyl)-11-methoxy-9a,13a-epoxy-3H,7H-4,14-dioxadibenz[a,j]anthracene-7,10,13-trione

C26H20O8 (460.1158)


   

Cetirizine Dihydrochloride

Cetirizine Dihydrochloride

C21H27Cl3N2O3 (460.1087)


   

glutaraldehyde 2,4-dinitrophenylhydrazone

glutaraldehyde 2,4-dinitrophenylhydrazone

C17H16N8O8 (460.1091)


   

6-Chloro-N-[(9H-fluoren-9-ylmethoxy)carbonyl]tryptoph

6-Chloro-N-[(9H-fluoren-9-ylmethoxy)carbonyl]tryptoph

C26H21ClN2O4 (460.119)


   

Levocetirizine dihydrochloride

Levocetirizine dihydrochloride

C21H27Cl3N2O3 (460.1087)


D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist Levocetirizine dihydrochloride ((R)-Cetirizine dihydrochloride) is a third-generation peripheral H1-receptor antagonist. Levocetirizine dihydrochloride is an antihistaminic agent which is the R-enantiomer of Cetirizine. Levocetirizine dihydrochloride has a higher affinity for the histamine H1-receptor than (S)-Cetirizine and can effectively treat allergic rhinitis and chronic idiopathic urticaria[1].

   

1,3,5-tri-O-benzoyl-2-oxo-α-D-erythro-pentofuranose

1,3,5-tri-O-benzoyl-2-oxo-α-D-erythro-pentofuranose

C26H20O8 (460.1158)


   

Losartan potassium

Losartan potassium

C22H22ClKN6O (460.1181)


C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C66930 - Angiotensin II Receptor Antagonist D057911 - Angiotensin Receptor Antagonists > D047228 - Angiotensin II Type 1 Receptor Blockers COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents B - Blood and blood forming organs > B03 - Antianemic preparations Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Losartan potassium (DuP-753 potassium) is an angiotensin II receptor type 1 (AT1) antagonist, competing with the binding of angiotensin II to AT1 with an IC50 of 20 nM.

   

Cetirizine hydrochloride

Cetirizine Dihydrochloride

C21H27Cl3N2O3 (460.1087)


D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist D018926 - Anti-Allergic Agents Cetirizine dihydrochloride, a second-generation antihistamine and the carboxylated metabolite of hydroxyzine, is a specific, orally active and long-acting histamine H1-receptor antagonist. Cetirizine dihydrochloride marks antiallergic properties and inhibits eosinophil chemotaxis during the allergic response[1][2][3].

   

Fmoc-6-chloro L-Tryptophan

Fmoc-6-chloro L-Tryptophan

C26H21ClN2O4 (460.119)


   

(S)-Cetirizine Dihydrochloride

(S)-Cetirizine Dihydrochloride

C21H27Cl3N2O3 (460.1087)


   

Ponesimod

Ponesimod

C23H25ClN2O4S (460.1223)


L - Antineoplastic and immunomodulating agents > L04 - Immunosuppressants > L04A - Immunosuppressants > L04AA - Selective immunosuppressants D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents > D000081243 - Sphingosine 1 Phosphate Receptor Modulators C308 - Immunotherapeutic Agent

   

2-(5-{5-[Amino(iminio)methyl]-1H-benzimidazol-2-YL}-2-fluoro-6-oxido-1,1-biphenyl-3-YL)succinate

2-(5-{5-[Amino(iminio)methyl]-1H-benzimidazol-2-YL}-2-fluoro-6-oxido-1,1-biphenyl-3-YL)succinate

C24H17FN4O5-2 (460.1183)


   

Aspartyl adenylate beta-ketophosphonate isostere

Aspartyl adenylate beta-ketophosphonate isostere

C15H21N6O9P (460.1108)


An organic phosphonate that is adenosine having a [(3S)-3-amino-4-carboxy-2-oxobutyl](hydroxy)phosphoryl group attached at position 5.

   

(5Z)-5-[[3-chloro-4-(2,3-dihydroxypropoxy)phenyl]methylidene]-3-(2-methylphenyl)-2-propylimino-1,3-thiazolidin-4-one

(5Z)-5-[[3-chloro-4-(2,3-dihydroxypropoxy)phenyl]methylidene]-3-(2-methylphenyl)-2-propylimino-1,3-thiazolidin-4-one

C23H25ClN2O4S (460.1223)


   

4-[[3-(3-methoxyphenyl)-3-oxopropylidene]amino]-N-quinoxalin-2-ylbenzenesulfonamide

4-[[3-(3-methoxyphenyl)-3-oxopropylidene]amino]-N-quinoxalin-2-ylbenzenesulfonamide

C24H20N4O4S (460.1205)


   

Anhydrochlortetracycline

Anhydrochlortetracycline

C22H21ClN2O7 (460.1037)


   
   

Cetirizine Impurity C (dihydrochloride)

Cetirizine Impurity C (dihydrochloride)

C21H27Cl3N2O3 (460.1087)


Cetirizine Impurity C dihydrochloride is an impurity of Cetirizine. Cetirizine, a second-generation antihistamine and the carboxylated metabolite of hydroxyzine, is a specific, orally active and long-acting histamine H1-receptor antagonist[1][2].

   

Octoclothepin (maleate salt)

Octoclothepin (maleate salt)

C23H25ClN2O4S (460.1223)


Octoclothepin maleate salt, an orally active neuroleptic agent, is a dual SR-2A and D2DR inhibitor. Octoclothepin maleate salt reveals an intensive central depressant action in a series of observational and instrumental procedures in rodents[1][2].

   

methyl (1r,2s,4r,5s,7s,9s,12r,14s,15r)-5-(chloromethyl)-2,7-dihydroxy-12-methyl-10,17-dioxo-6,16,18,19-tetraoxapentacyclo[12.2.2.1⁴,⁷.1⁹,¹².0¹,¹⁵]icosane-5-carboxylate

methyl (1r,2s,4r,5s,7s,9s,12r,14s,15r)-5-(chloromethyl)-2,7-dihydroxy-12-methyl-10,17-dioxo-6,16,18,19-tetraoxapentacyclo[12.2.2.1⁴,⁷.1⁹,¹².0¹,¹⁵]icosane-5-carboxylate

C20H25ClO10 (460.1136)


   

4,4'-dihydroxy-3-(4-hydroxyphenyl)-2',10'-dioxaspiro[furan-2,12'-tricyclo[12.2.2.1³,⁷]nonadecane]-1'(16'),3'(19'),4',6',14',17'-hexaene-5,11'-dione

4,4'-dihydroxy-3-(4-hydroxyphenyl)-2',10'-dioxaspiro[furan-2,12'-tricyclo[12.2.2.1³,⁷]nonadecane]-1'(16'),3'(19'),4',6',14',17'-hexaene-5,11'-dione

C26H20O8 (460.1158)


   

methyl 5-(chloromethyl)-2,7-dihydroxy-12-methyl-10,17-dioxo-6,16,18,19-tetraoxapentacyclo[12.2.2.1⁴,⁷.1⁹,¹².0¹,¹⁵]icosane-5-carboxylate

methyl 5-(chloromethyl)-2,7-dihydroxy-12-methyl-10,17-dioxo-6,16,18,19-tetraoxapentacyclo[12.2.2.1⁴,⁷.1⁹,¹².0¹,¹⁵]icosane-5-carboxylate

C20H25ClO10 (460.1136)


   

(1r,4s,5s,11r,14s,15s)-15-hydroxy-1,11-bis(methylsulfanyl)-2,12-dioxo-3,13-diazapentacyclo[11.7.0.0³,¹¹.0⁴,⁹.0¹⁴,¹⁹]icosa-6,8,16,18-tetraen-5-yl acetate

(1r,4s,5s,11r,14s,15s)-15-hydroxy-1,11-bis(methylsulfanyl)-2,12-dioxo-3,13-diazapentacyclo[11.7.0.0³,¹¹.0⁴,⁹.0¹⁴,¹⁹]icosa-6,8,16,18-tetraen-5-yl acetate

C22H24N2O5S2 (460.1127)


   

(1r,2r,14s,15r)-4,24-dimethoxy-8,15-dimethyl-9,13,16,20-tetraoxaheptacyclo[13.11.0.0²,¹⁴.0³,¹².0⁵,¹⁰.0¹⁷,²⁵.0¹⁹,²³]hexacosa-3(12),4,7,10,17(25),18,21,23-octaene-6,26-dione

(1r,2r,14s,15r)-4,24-dimethoxy-8,15-dimethyl-9,13,16,20-tetraoxaheptacyclo[13.11.0.0²,¹⁴.0³,¹².0⁵,¹⁰.0¹⁷,²⁵.0¹⁹,²³]hexacosa-3(12),4,7,10,17(25),18,21,23-octaene-6,26-dione

C26H20O8 (460.1158)


   

(1s,3s,7s,8s,9r,10s,17r,18s,19s,20r)-9,18,19,20-tetrahydroxy-9-methyl-12,14-dioxo-2,4,11,15,21-pentaoxatetracyclo[15.3.1.1⁷,¹⁰.0³,⁸]docos-5-ene-6-carboxylic acid

(1s,3s,7s,8s,9r,10s,17r,18s,19s,20r)-9,18,19,20-tetrahydroxy-9-methyl-12,14-dioxo-2,4,11,15,21-pentaoxatetracyclo[15.3.1.1⁷,¹⁰.0³,⁸]docos-5-ene-6-carboxylic acid

C19H24O13 (460.1217)


   

(1s,12r,22s)-3,7,17-trihydroxy-9,15-dimethyl-13,19-dioxo-20-oxahexacyclo[10.9.1.1¹,¹⁴.0²,¹¹.0⁵,¹⁰.0¹⁸,²³]tricosa-2(11),3,5,7,9,14,16,18(23)-octaen-22-yl acetate

(1s,12r,22s)-3,7,17-trihydroxy-9,15-dimethyl-13,19-dioxo-20-oxahexacyclo[10.9.1.1¹,¹⁴.0²,¹¹.0⁵,¹⁰.0¹⁸,²³]tricosa-2(11),3,5,7,9,14,16,18(23)-octaen-22-yl acetate

C26H20O8 (460.1158)


   

15-hydroxy-1,11-bis(methylsulfanyl)-2,12-dioxo-3,13-diazapentacyclo[11.7.0.0³,¹¹.0⁴,⁹.0¹⁴,¹⁹]icosa-6,8,16,18-tetraen-5-yl acetate

15-hydroxy-1,11-bis(methylsulfanyl)-2,12-dioxo-3,13-diazapentacyclo[11.7.0.0³,¹¹.0⁴,⁹.0¹⁴,¹⁹]icosa-6,8,16,18-tetraen-5-yl acetate

C22H24N2O5S2 (460.1127)


   

(3s)-3-amino-5-{[(2r,3s,4r,5r)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy(hydroxy)phosphoryl}-4-oxopentanoic acid

(3s)-3-amino-5-{[(2r,3s,4r,5r)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy(hydroxy)phosphoryl}-4-oxopentanoic acid

C15H21N6O9P (460.1108)


   

(2r)-4,4'-dihydroxy-3-(4-hydroxyphenyl)-2',10'-dioxaspiro[furan-2,12'-tricyclo[12.2.2.1³,⁷]nonadecane]-1'(16'),3'(19'),4',6',14',17'-hexaene-5,11'-dione

(2r)-4,4'-dihydroxy-3-(4-hydroxyphenyl)-2',10'-dioxaspiro[furan-2,12'-tricyclo[12.2.2.1³,⁷]nonadecane]-1'(16'),3'(19'),4',6',14',17'-hexaene-5,11'-dione

C26H20O8 (460.1158)


   

9,18,19,20-tetrahydroxy-9-methyl-12,14-dioxo-2,4,11,15,21-pentaoxatetracyclo[15.3.1.1⁷,¹⁰.0³,⁸]docos-5-ene-6-carboxylic acid

9,18,19,20-tetrahydroxy-9-methyl-12,14-dioxo-2,4,11,15,21-pentaoxatetracyclo[15.3.1.1⁷,¹⁰.0³,⁸]docos-5-ene-6-carboxylic acid

C19H24O13 (460.1217)


   

7,7'-diacetyl-8,8'-dihydroxy-6,6'-dimethyl-7,8-dihydro-[2,2'-binaphthalene]-1,1',4,4'-tetrone

7,7'-diacetyl-8,8'-dihydroxy-6,6'-dimethyl-7,8-dihydro-[2,2'-binaphthalene]-1,1',4,4'-tetrone

C26H20O8 (460.1158)


   

(7r,8s)-7,7'-diacetyl-8,8'-dihydroxy-6,6'-dimethyl-7,8-dihydro-[2,2'-binaphthalene]-1,1',4,4'-tetrone

(7r,8s)-7,7'-diacetyl-8,8'-dihydroxy-6,6'-dimethyl-7,8-dihydro-[2,2'-binaphthalene]-1,1',4,4'-tetrone

C26H20O8 (460.1158)


   

2-hydroxy-2-{2-oxo-2-[(4-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)methoxy]ethyl}butanedioic acid

2-hydroxy-2-{2-oxo-2-[(4-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)methoxy]ethyl}butanedioic acid

C19H24O13 (460.1217)


   

(1s,3s,9r,10s,17r,18s,19s,20r)-9,18,19,20-tetrahydroxy-9-methyl-12,14-dioxo-2,4,11,15,21-pentaoxatetracyclo[15.3.1.1⁷,¹⁰.0³,⁸]docos-5-ene-6-carboxylic acid

(1s,3s,9r,10s,17r,18s,19s,20r)-9,18,19,20-tetrahydroxy-9-methyl-12,14-dioxo-2,4,11,15,21-pentaoxatetracyclo[15.3.1.1⁷,¹⁰.0³,⁸]docos-5-ene-6-carboxylic acid

C19H24O13 (460.1217)


   

(1s,3r,7s,8s,9s,10r,17s,18r,19r,20r)-9,18,19,20-tetrahydroxy-9-methyl-12,14-dioxo-2,4,11,15,21-pentaoxatetracyclo[15.3.1.1⁷,¹⁰.0³,⁸]docos-5-ene-6-carboxylic acid

(1s,3r,7s,8s,9s,10r,17s,18r,19r,20r)-9,18,19,20-tetrahydroxy-9-methyl-12,14-dioxo-2,4,11,15,21-pentaoxatetracyclo[15.3.1.1⁷,¹⁰.0³,⁸]docos-5-ene-6-carboxylic acid

C19H24O13 (460.1217)